Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

77.83 +5.00 (+6.87%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
31 32 Next >
(DXCM) - Analyzing DexCom's Short Interest
Via Benzinga
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review
Many leaders flashed buy signals as the indexes rebounded from support. 
Via Investor's Business Daily
1 High-Flying Growth Stock With 19% Upside, According to Wall Street
This company could keep going up, but beware of the risks. 
Via The Motley Fool
Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices
The decision came months ahead of Dexcom's and Abbott's expectations. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
2 No-Brainer Growth Stocks to Buy Right Now
Don't let these incredible businesses pass you by. 
Via The Motley Fool
Looking Into DexCom's Return On Capital Employed
Via Benzinga
Analyst Ratings for DexCom
Via Benzinga
Where to Invest $1,000 in a 2023 Nasdaq Bear Market
Even a modest investment in great companies can pay off over the long run. 
Via The Motley Fool
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
The continuous glucose monitoring market could heat up. 
Via The Motley Fool
What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?
DarioHealth (NASDAQ: DRIO) Partners With Dexcom (NASDAQ: DXCM) The Global Leader in Continuous Glucose Monitoring (CGM) To Integrate Dario's Multi-Chronic Condition Platform. 
Via News Direct
Better Buy: Abbott Laboratories or DexCom Stock?
Both stocks should benefit from the growth in diabetes care. 
Via The Motley Fool
2 Stock-Split Stocks with Explosive Potential to Buy in 2023
Don't let these top stocks pass you by. 
Via The Motley Fool
Dexcom Announces Upcoming Conference Presentations
From DexCom, Inc.
Via Business Wire
DexCom (DXCM) Q4 2022 Earnings Call Transcript
DXCM earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Dexcom Slumps As A New Rival Reportedly Arrives On Scene: Apple
Apple is reportedly making a bid for the diabetes market with new Apple Watch tech. 
Via Investor's Business Daily
What Does Apple Have To Do With DexCom Stock Trading Lower?
DexCom shares (NASDAQ: DXCM) are trading lower on Wednesday following a report that Apple Inc (NASDAQ: AAPL) is making progress on no-prick glucose tracking for its Watch. 
Via Benzinga
My 3 Biggest Stock Market Predictions for March
These three trends will likely drive revenue and share prices. 
Via The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These stocks have something to offer every type of investor. 
Via The Motley Fool
2 Exceptional Growth Stocks Billionaires Keep Buying With Both Hands
A poor performance from the broad market didn't stop these billionaire hedge fund managers from placing big bets on three supercharged growth stocks. 
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
This healthcare space is bursting with opportunity for long-term investors. 
Via The Motley Fool
Deere Leads 5 Stocks With Hot Products Near Buy Points
Deere and Dexcom lead this weekend list of 5 stocks near buy points. 
Via Investor's Business Daily
Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them
Super Bowl LVII aired Sunday Feb. 12, 2023 and featured dozens of commercials advertising products and showcasing new movies and television shows. The commercials also featured many celebrity cameos... 
Via Benzinga
2 Growth Stocks That Could Help Make You a Fortune
These companies have what it takes to deliver outsized returns over the long haul. 
Via The Motley Fool
Cramer: This Big US Bank Stock Can 'Go Much Higher In This Environment'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said A. O. 
Via Benzinga
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
From Dexcom, Inc.
Via Business Wire
2 Top Healthcare Stocks to Buy for the Long Haul
The healthcare industry is booming, and this presents no shortage of opportunities to invest in promising businesses. 
Via The Motley Fool
Stock Market Pulls Back As Treasury Yields Jump; Google Dives On AI Flop: Weekly Review
Is this a normal, healthy pullback or the start of something more? 
Via Investor's Business Daily
Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
The Super Bowl LVII Commercials List: From A Breaking Bad Reunion To Ozzy Osbourne, The Celebrities And 21 Stocks To Watch
A 30-second commercial during Super Bowl LVII costs around $7 million. For some companies hoping to increase their brand recognition or introduce a new product, the price is worth it. 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.